Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BLL003
MIFTS: 53

Bell's Palsy

Categories: Eye diseases, Infectious diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bell's Palsy

About this section

MalaCards integrated aliases for Bell's Palsy:

Name: Bell's Palsy 12 77 54 55 44 15 17
Bell Palsy 12 54 45 74
Facial Paralysis 54 74
Facial Cranial Nerve Paralysis 54
Idiopathic Facial Palsy 54
Refrigeration Palsy 54
Facial Nerve Palsy 54
Bell's Palsy 12
Antoni's Palsy 54
Facial Palsy 54

Classifications:

MalaCards categories:
Global: Rare diseases Infectious diseases
Anatomical: Neuronal diseases Eye diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:12506
ICD9CM 36 351.0
MeSH 45 D020330
SNOMED-CT 69 79359001
ICD10 34 G51.0
Sources

Summaries for Bell's Palsy

About this section
NINDS : 55 Bell's palsy is a form of temporary facial paralysis resulting from damage or trauma to the 7th cranial nerve, one of the facial nerves. It is the most common cause of facial paralysis. Generally, Bell's palsy affects only one side of the face, but it can affect both sides. Symptoms vary among individuals and include sudden weakness on one side of the face, drooping eyelid or corner of the mouth, drooling, inability to close the eye or mouth, altered taste, and excessive tearing in the eye. Symptoms appear suddenly and reach their peak within 72 hours. Bell's palsy can range in severity from mild weakness to total paralysis, and can cause significant facial distortion. The exact cause of Bell's palsy isn't known, but many scientists believe that reactivation of a dormant viral infection can cause the facial nerve to swell and become inflamed. Several other conditions can cause facial paralysis that might be diagnosed as Bell's palsy. The disorder can affect anyone at any age. Risk factors include pregnancy, preeclampsia, obesity, hypertention, diabetes, and upper respiratory ailments.

MalaCards based summary : Bell's Palsy, also known as bell palsy, is related to facial paralysis and essential tremor, and has symptoms including seizures, muscle weakness and tremor. An important gene associated with Bell's Palsy is HS1BP3 (HCLS1 Binding Protein 3). The drugs Methylprednisolone hemisuccinate and Prednisolone phosphate have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and neutrophil.

Disease Ontology : 12 A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).

NIH Rare Diseases : 54 Bell's palsy is a form of temporary facial paralysis which results from damage or trauma to one of the facial nerves. This disorder is characterized by the sudden onset of facial paralysis that often affects just one side and can cause significant facial distortion. Symptoms vary, but may include twitching, weakness, drooping eyelid or corner of the mouth, drooling, dry eye or mouth, impairment of taste, and excessive tearing in the eye. While the exact cause is unknown, many researchers believe that a virus may lead to swelling of the 7th cranial nerve. Steroids, such as prednisone, may reduce the inflammation and swelling. Other medications used to treat Bell's palsy include acyclovir (to fight viral infections) and aspirin, acetaminophen, or ibuprofen (to relieve pain).Physical therapy, facial massage and acupuncture have also been used.

MedlinePlus : 44 Bell's palsy is the most common cause of facial paralysis. It usually affects just one side of the face. Symptoms appear suddenly and are at their worst about 48 hours after they start. They can range from mild to severe and include Twitching Weakness Paralysis Drooping eyelid or corner of mouth Drooling Dry eye or mouth Excessive tearing in the eye Impaired ability to taste Scientists think that a viral infection makes the facial nerve swell or become inflamed. You are most likely to get Bell's palsy if you are pregnant, diabetic or sick with a cold or flu. Three out of four patients improve without treatment. With or without treatment, most people begin to get better within 2 weeks and recover completely within 3 to 6 months. NIH: National Institute of Neurological Disorders and Stroke

Wikipedia : 77 Bell''s palsy is a type of facial paralysis that results in an inability to control the facial muscles... more...

Sources

Related Diseases for Bell's Palsy

About this section

Diseases related to Bell's Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 375)
# Related Disease Score Top Affiliating Genes
1 facial paralysis 30.8 HOXB1 LIPN
2 essential tremor 29.4 HS1BP3 PRKN
3 facial palsy, congenital, with ptosis and velopharyngeal dysfunction 12.4
4 recurrent peripheral facial palsy 12.3
5 congenital hereditary facial paralysis-variable hearing loss syndrome 12.2
6 deafness, conductive stapedial, with ear malformation and facial palsy 12.2
7 aortic arch interruption, facial palsy, and retinal coloboma 12.1
8 anotia facial palsy cardiac defect 12.1
9 facial palsy, familial recurrent peripheral 11.6
10 lyme disease 11.6
11 urofacial syndrome 1 11.5
12 lyme disease - neurological complications 11.3
13 neurilemmoma 11.2
14 carey-fineman-ziter syndrome 11.2
15 facial paresis, hereditary congenital, 1 11.1
16 craniometaphyseal dysplasia, autosomal dominant 11.1
17 craniometaphyseal dysplasia, autosomal recessive 11.1
18 facial paresis, hereditary congenital, 3 11.1
19 sclerosteosis 1 11.1
20 sclerosteosis 2 11.1
21 orofacial granulomatosis 11.1
22 familial amyloidosis, finnish type 11.1
23 osteopetrosis, autosomal recessive 1 11.0
24 osteopathia striata with cranial sclerosis 11.0
25 thiamine metabolism dysfunction syndrome 2 11.0
26 lethal congenital contracture syndrome 2 11.0
27 sclerosteosis 11.0
28 biotin-thiamine-responsive basal ganglia disease 11.0
29 amyloidosis, finnish type 10.9
30 camurati-engelmann disease 10.9
31 charlie m syndrome 10.9
32 herpes simplex 10.6
33 diabetes mellitus 10.5
34 myoclonus and ataxia 10.5
35 hepatitis 10.4
36 herpes zoster 10.3
37 neuropathy 10.3
38 hemifacial spasm 10.3
39 blepharospasm 10.3
40 influenza 10.3
41 pfeiffer syndrome 10.2
42 pre-eclampsia 10.2
43 eclampsia 10.2
44 polyneuropathy 10.2
45 geniculate herpes zoster 10.2
46 bone fracture 10.2
47 acoustic neuroma 10.2
48 neuroma 10.2
49 hepatitis b 10.2
50 hepatitis c 10.2

Graphical network of the top 20 diseases related to Bell's Palsy:



Diseases related to Bell's Palsy
Sources

Symptoms & Phenotypes for Bell's Palsy

About this section

UMLS symptoms related to Bell's Palsy:


seizures, muscle weakness, tremor, generalized muscle weakness, back pain, ophthalmoplegia, pain, headache, hemiplegia, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness, oral manifestations, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, flaccid muscle tone
Sources

Drugs & Therapeutics for Bell's Palsy

About this section

Drugs for Bell's Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 110)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Not Applicable 2921-57-5
2
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 302-25-0
3
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-24-8 5755
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 83-43-2 6741
5
Acetylcholine Approved, Investigational Phase 4,Not Applicable 51-84-3 187
6
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
7
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Not Applicable 2920-86-7
8
Cortisone Experimental Phase 4 53-06-5 222786
9 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable
10 Neuroprotective Agents Phase 4,Phase 3,Not Applicable
11 Methylprednisolone Acetate Phase 4,Phase 3,Phase 2,Not Applicable
12 Autonomic Agents Phase 4,Phase 3,Phase 2,Not Applicable
13 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
14 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
15 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
16 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
17 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Not Applicable
19 Antiemetics Phase 4,Phase 3,Phase 2,Not Applicable
20 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Not Applicable
21 Protective Agents Phase 4,Phase 3,Not Applicable
22 Prednisolone acetate Phase 4,Phase 3,Phase 2,Not Applicable
23 valacyclovir Phase 4,Not Applicable
24 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
25 Antiviral Agents Phase 4,Not Applicable,Early Phase 1
26 Botulinum Toxins, Type A Phase 4,Not Applicable
27 Neuromuscular Agents Phase 4,Not Applicable
28 Botulinum Toxins Phase 4,Not Applicable
29 Neurotransmitter Agents Phase 4,Not Applicable
30 Cholinergic Agents Phase 4,Not Applicable
31 incobotulinumtoxinA Phase 4
32 Acetylcholine Release Inhibitors Phase 4,Not Applicable
33 abobotulinumtoxinA Phase 4,Not Applicable
34 Vaccines Phase 4,Phase 3,Phase 2
35 Immunologic Factors Phase 4,Phase 3
36 Anti-Arrhythmia Agents Phase 4,Phase 3,Not Applicable
37 Anesthetics Phase 4,Phase 3,Phase 2,Not Applicable
38 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
39 Diuretics, Potassium Sparing Phase 4,Not Applicable
40 Anesthetics, Local Phase 4,Not Applicable
41 Sodium Channel Blockers Phase 4,Not Applicable
42
Prednisone Approved, Vet_approved Phase 2, Phase 3,Not Applicable,Early Phase 1 53-03-2 5865
43
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
44
Nicardipine Approved, Investigational Phase 3,Phase 1 55985-32-5 4474
45
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3,Not Applicable 1177-87-3
46
Benzocaine Approved, Investigational Phase 2, Phase 3,Phase 3 94-09-7, 1994-09-7 2337
47
tannic acid Approved Phase 2, Phase 3,Phase 3 1401-55-4
48
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3,Not Applicable 50-02-2 5743
49
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
50
Diltiazem Approved, Investigational Phase 3 42399-41-7 39186

Interventional clinical trials:

(show top 50) (show all 85)
# Name Status NCT ID Phase Drugs
1 Scandinavian Bell's Palsy Study Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
3 A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults Completed NCT01427309 Phase 4
4 Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy Not yet recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
5 Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
6 Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery Completed NCT00438087 Phase 3 methylprednisolone
7 Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 Completed NCT01604746 Phase 3
8 Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial Completed NCT00059332 Phase 3 Magnesium Sulfate;Normal Saline
9 A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis Completed NCT02020889 Phase 3 Placebo
10 Intratympanic Steroid for Bell's Palsy Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
11 Neuroprotectant for Hypertensive Intracerebral Hemorrhage Not yet recruiting NCT03546283 Phase 3 Placebos;Cattle Encephalon Glycoside and Ignotin
12 Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older Terminated NCT00976027 Phase 3
13 Antihypertensive Treatment of Acute Cerebral Hemorrhage-II Terminated NCT01176565 Phase 3 Intravenous nicardipine hydrochloride
14 Quadrant Versus Superficial Parotidectomy Withdrawn NCT01607866 Phase 2, Phase 3
15 Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study Withdrawn NCT01614977 Phase 3 Methylprednisoline
16 Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children Completed NCT01777633 Phase 1, Phase 2
17 Seasonal Flu Vaccine in Adult Transplant Recipients Completed NCT01258023 Phase 2
18 Contrastim Stroke Trial Completed NCT01049802 Phase 1, Phase 2
19 A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma Completed NCT01153763 Phase 2 GSK2118436
20 A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Recruiting NCT02785120 Phase 2 TF0023
21 Activated Protein C in Acute Stroke Trial Terminated NCT00533546 Phase 2 Activated Protein C
22 Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Terminated NCT01127503 Phase 2 Metyrosine;Placebo
23 Antihypertensive Treatment in Acute Cerebral Hemorrhage Completed NCT00415610 Phase 1 nicardipine
24 The Relationship Between Psychological Factors and Bell's Palsy Unknown status NCT01377766
25 Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China Unknown status NCT01201642 Not Applicable Prednisolone
26 Quantification, Analysis and Simulation of Facial Mimics Movements Unknown status NCT02002572 Not Applicable
27 Two Different Surgical Methods of Blepharospasm Unknown status NCT02765113 Early Phase 1
28 Comparing the Behavior of the Cardiac Autonomic Regulation System During 24h in Patient Post Stroke and Controls Unknown status NCT02735616
29 A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy Completed NCT01686464 Not Applicable prednisone and valacyclovir treatments
30 Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages Completed NCT00608660 Not Applicable
31 Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy Completed NCT00685789 Not Applicable
32 Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy Completed NCT00561106 Not Applicable prednisone- valacyclovir;prednisone-placebo
33 Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy Completed NCT02328079 Not Applicable Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
34 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
35 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
36 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
37 Myofunctional Therapy in Facial Palsy Completed NCT00989209 Not Applicable Botulinum Toxin Type A
38 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis Completed NCT01327157 Not Applicable
39 Cognitive Function and Emotional Possessing in Bilateral Facial Palsy Completed NCT02179450
40 Complications in Parotid Surgery Completed NCT02486393
41 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
42 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226 Not Applicable
43 The Prehospital Selection of Acute Stroke Patients Completed NCT03072524
44 Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Completed NCT01985997
45 Clinical Research Core Dental Screening Protocol Completed NCT00090818
46 National Prospective and Comparative Study on the Mode of Delivery of Twins Completed NCT01987063
47 Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines Completed NCT02893878
48 Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp) Completed NCT02437409
49 General Anesthesia With or Without Local Ear Block in Middle Ear Surgeries Completed NCT03569046 Not Applicable local anaesthetic injection;Normal Saline Flush, 0.9% Injectable Solution;general anesthetic;Hypotensives
50 Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine Completed NCT00258882

Search NIH Clinical Center for Bell's Palsy

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: bell palsy

Sources

Genetic Tests for Bell's Palsy

About this section
Sources

Anatomical Context for Bell's Palsy

About this section

MalaCards organs/tissues related to Bell's Palsy:

42
Eye, Testes, Neutrophil, Bone, Brain, Tongue, Skin
Sources

Publications for Bell's Palsy

About this section

Articles related to Bell's Palsy:

(show top 50) (show all 1332)
# Title Authors Year
1
Computer vision technology-based face mirroring system providing mirror therapy for Bell's palsy patients. ( 30634878 )
2019
2
Neonatal Bell's Palsy and Possible Correlation with Human Leukocyte Antigens. ( 30671192 )
2019
3
Letter in Reply: "Neonatal Bell's Palsy and Possible Correlation with Human Leukocyte Antigens". ( 30671193 )
2019
4
Recurrent Bell's palsy. ( 30672667 )
2019
5
Comparative prognosis in patients with Ramsay-Hunt syndrome and Bell's palsy. ( 30707280 )
2019
6
Does Herpes 6 Infection have a Role in Bell's Palsy Among Children and Adolescents? ( 30724837 )
2019
7
Clinical efficacy and safety of thread-embedding acupuncture for treatment of the sequelae of Bell's palsy: A protocol for a patient-assessor blinded, randomized, controlled, parallel clinical trial. ( 30762782 )
2019
8
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Hematologic Markers of Bell's Palsy: A Meta-analysis. ( 30807521 )
2019
9
Morphometric analysis of CT scans of the facial canal in Bell's palsy: a study of 51 patients. ( 30888701 )
2019
10
Bell's palsy and Guillain-Barré syndrome may be two ends of the same spectrum. ( 30908681 )
2019
11
Bell Palsy and the Risk of Cardio-Cerebrovascular Disease: A Population-Based Follow-Up Study. ( 30632167 )
2019
12
A study of affecting the recovery of Chinese patients with Bell palsy. ( 30681613 )
2019
13
The effect of metabolic syndrome on Bell's palsy recovery rate. ( 29374993 )
2018
14
Prognostic role of neurophysiological testing 3-7 days after onset of acute unilateral Bell's palsy. ( 29496378 )
2018
15
Prognostic value of the blink reflex test in Bell's palsy and Ramsay-Hunt syndrome. ( 29402606 )
2018
16
A Case of An Unusual Bell's Palsy Mimic. ( 29961527 )
2018
17
Pontine haemorrhage disguised as Bell's palsy. ( 29437741 )
2018
18
Augmentation effect of acupuncture on Bi'nao for hypophasis in patients with Bell's palsy: study protocol for a randomized controlled trial. ( 29891003 )
2018
19
Delayed facial nerve decompression for severe refractory cases of Bell's palsy: a 25-year experience. ( 29301560 )
2018
20
A Case of Bell's Palsy Complicated by Subsequent Herpes Simplex Virus Encephalitis. ( 29144221 )
2018
21
Prevalence and characteristics of hearing loss in patients diagnosed with Bell's Palsy. ( 29164322 )
2018
22
Idiopathic Non-traumatic Facial Nerve Palsy (Bell's Palsy) in Neonates; An Atypical Age and Management Dilemma. ( 29468002 )
2018
23
A Case Report of a Child with Bell's Palsy. ( 29872589 )
2018
24
Bell's palsy treated with photobiomodulation in an adolescent: Rare case report and review of the published literature. ( 30218464 )
2018
25
Systematic Review of Facial Nerve Outcomes After Middle Fossa Decompression and Transmastoid Decompression for Bell's Palsy With Complete Facial Paralysis. ( 30239428 )
2018
26
Comparison of conservative therapy and steroid therapy for Bell's palsy in children. ( 30304913 )
2018
27
Radiation Exposure and Bell's Palsy: A Hypothetical Association. ( 30320038 )
2018
28
A report of Bell's Palsy triggered by leptomeningeal metastases from recurrent high grade serous ovarian cancer. ( 30417064 )
2018
29
Altered Brain Fraction Amplitude of Low Frequency Fluctuation at Resting State in Patients With Early Left and Right Bell's Palsy: Do They Have Differences? ( 30450029 )
2018
30
The Epidemiology and Management of Bell's Palsy in the Sudan. ( 30505363 )
2018
31
Association Between High Neutrophil to Lymphocyte Ratio and Delayed Recovery From Bell's Palsy. ( 30545211 )
2018
32
Increased incidence of Bell's palsy with worse outcomes in pregnancy. ( 30007744 )
2018
33
Evidence for Seasonal Variation of Bell's Palsy in Germany. ( 30092584 )
2018
34
Antivirals With Corticosteroids for the Treatment of Acute Bell's Palsy. ( 30182458 )
2018
35
Weather, Weather Changes and the Risk of Bell's Palsy: A Multicenter Case-Crossover Study. ( 30205396 )
2018
36
Bell's Palsy-Tertiary Ischemia: An Etiological Factor in Residual Facial Palsy. ( 30211092 )
2018
37
Bilateral taste disorders in patients with Ramsay Hunt syndrome and Bell palsy. ( 29537615 )
2018
38
Retina Folds and Subretinal Fluid After Bell Palsy. ( 28983569 )
2018
39
Does the Degree of the Mastoid Pneumatization Affect the Side of Bell Palsy? ( 29485553 )
2018
40
Prognosis of Bell Palsy: A Clinical, Neurophysiological, and Ultrasound Study. ( 30387782 )
2018
41
Serum levels of oxidative stress indicators and antioxidant enzymes in Bell palsy. ( 30481849 )
2018
42
Usefulness of High-Resolution 3D Multi-Sequences for Peripheral Facial Palsy: Differentiation Between Bell's Palsy and Ramsay Hunt Syndrome. ( 29135869 )
2017
43
Does Type 2 Diabetes Mellitus Affect the Healing of Bell's Palsy in Adults? ( 29284561 )
2017
44
Recurrent Bell's palsy following ventriculoperitoneal shunt insertion: an unusual case to face. ( 29191062 )
2017
45
Increased risk of peripheral arterial occlusive disease in patients with Bell's palsy using population data. ( 29216223 )
2017
46
Bell's Palsy in Children (BellPIC): protocol for a multicentre, placebo-controlled randomized trial. ( 28193257 )
2017
47
Bell's palsy in children: Current treatment patterns in Australia and New Zealand. A PREDICT study. ( 28177168 )
2017
48
Disrupted functional connectivity of striatal sub-regions in Bell's palsy patients. ( 28180070 )
2017
49
Oxidative Stress and Antioxidant Status in Patients with Bell's Palsy. ( 28680345 )
2017
50
Facial nerve palsy in a child: Bell's palsy? Think again! ( 29527278 )
2017
Sources

Variations for Bell's Palsy

About this section

ClinVar genetic disease variations for Bell's Palsy:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 46;XX;t(1;13)(q11.2;p11.2)dn Translocation Uncertain significance
Sources

Expression for Bell's Palsy

About this section
Search GEO for disease gene expression data for Bell's Palsy.
Sources

Pathways for Bell's Palsy

About this section
Sources

GO Terms for Bell's Palsy

About this section

Cellular components related to Bell's Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 azurophil granule lumen GO:0035578 8.62 DEFA1 DEFA3

Biological processes related to Bell's Palsy according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 defense response to Gram-positive bacterium GO:0050830 9.52 DEFA1 DEFA3
2 defense response to Gram-negative bacterium GO:0050829 9.51 DEFA1 DEFA3
3 defense response to virus GO:0051607 9.5 DEFA1 DEFA3 MX1
4 antimicrobial humoral immune response mediated by antimicrobial peptide GO:0061844 9.49 DEFA1 DEFA3
5 antimicrobial humoral response GO:0019730 9.48 DEFA1 DEFA3
6 killing of cells of other organism GO:0031640 9.46 DEFA1 DEFA3
7 antibacterial humoral response GO:0019731 9.43 DEFA1 DEFA3
8 defense response to fungus GO:0050832 9.4 DEFA1 DEFA3
9 innate immune response in mucosa GO:0002227 9.37 DEFA1 DEFA3
10 intracellular estrogen receptor signaling pathway GO:0030520 9.26 DEFA1 DEFA3
11 mitochondrial fission GO:0000266 9.16 MX1 PRKN
12 defense response GO:0006952 9.13 DEFA1 DEFA3 MX1
13 membrane disruption in other organism GO:0051673 8.62 DEFA1 DEFA3
Sources

Sources for Bell's Palsy

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....